QuatRx Pharmaceuticals' Unattributed VC Round

QuatRx Pharmaceuticals raised a round of funding on January 07, 2002.

QuatRx Pharmaceuticals Company is focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. In addition to QRX-431, …

Articles about QuatRx Pharmaceuticals' Unattributed VC Round: